Literature DB >> 14593216

Upregulation of p55 and p75 receptors mediating TNF-alpha transport across the injured blood-spinal cord barrier.

Weihong Pan1, Balazs Csernus, Abba J Kastin.   

Abstract

Tumor necrosis factor (TNF-alpha) is involved in the inflammation and tissue regeneration occurring after spinal cord injury (SCI). This study tests the specific role of p55 and p75 receptors in mediating the transport of TNF-alpha across the blood-spinal cord barrier (BSCB) after SCI by compression. Transcytosis of 125I-TNF-alpha across a monolayer of the cerebral endothelial cells that compose the blood-brain barrier was significantly reduced in the absence of functional p55 and p75 receptors. At 3 d after SCI, double receptor knockout mice had a significantly reduced increase in TNF-alpha uptake from blood to injured lumbar spinal cord as compared with their inbred controls, despite the similar extent of BSCB disruption (measured by 99mTc-albumin). The p75 single receptor knockout mice had a reduced increase in 125I-TNF-alpha uptake, whereas the p55 receptor knockout mice had no significant increase of 125I-TNF-alpha uptake after SCI, suggesting that the p55 receptor plays a major role. Hence, the increased uptake of TNF-alpha 3 d after SCI is not explained by nonspecific barrier disruption but by receptor-mediated upregulation of transport. Quantitative RT-PCR analysis further showed that upregulation of TNF-alpha transport was related to increased expression of mRNA for p55 and p75 receptors. The increase of p55 receptor expression was more robust and seen between 12 h and 1 wk after SCI, whereas the increase of p75 receptor expression occurred later and involved fewer regions. Thus, the differential upregulation of p55 and p75 receptors indicates that permeation of TNF-alpha across the injured BSCB remains a regulated process. Knowledge of receptor-mediated regulation could facilitate effective therapeutic manipulation of BSCB permeation of vascular cytokines important to CNS regeneration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14593216     DOI: 10.1385/JMN:21:2:173

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  26 in total

1.  Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury.

Authors:  W Pan; W A Banks; A J Kastin
Journal:  Exp Neurol       Date:  1997-08       Impact factor: 5.330

2.  Spinal cord compression injury in guinea pigs: structural changes of endothelium and its perivascular cell associations after blood-brain barrier breakdown and repair.

Authors:  C B Jaeger; A R Blight
Journal:  Exp Neurol       Date:  1997-04       Impact factor: 5.330

Review 3.  Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology.

Authors:  J S Pober
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

4.  Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway.

Authors:  W K Kim; Y Kan; D Ganea; R P Hart; I Gozes; G M Jonakait
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

Review 5.  TNF signaling in vascular endothelial cells.

Authors:  L A Madge; J S Pober
Journal:  Exp Mol Pathol       Date:  2001-06       Impact factor: 3.362

6.  Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats.

Authors:  J R Bethea; H Nagashima; M C Acosta; C Briceno; F Gomez; A E Marcillo; K Loor; J Green; W D Dietrich
Journal:  J Neurotrauma       Date:  1999-10       Impact factor: 5.269

7.  The blood-spinal cord barrier after injury: pattern of vascular events proximal and distal to a transection in the rat.

Authors:  L J Noble; J R Wrathall
Journal:  Brain Res       Date:  1987-10-20       Impact factor: 3.252

Review 8.  Tumor necrosis factor-alpha: a neuromodulator in the CNS.

Authors:  W Pan; J E Zadina; R E Harlan; J T Weber; W A Banks; A J Kastin
Journal:  Neurosci Biobehav Rev       Date:  1997-09       Impact factor: 8.989

9.  TNFalpha transport across the blood-brain barrier is abolished in receptor knockout mice.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Exp Neurol       Date:  2002-04       Impact factor: 5.330

10.  Role of tumor necrosis factor-alpha in neuronal and glial apoptosis after spinal cord injury.

Authors:  Y B Lee; T Y Yune; S Y Baik; Y H Shin; S Du; H Rhim; E B Lee; Y C Kim; M L Shin; G J Markelonis; T H Oh
Journal:  Exp Neurol       Date:  2000-11       Impact factor: 5.330

View more
  17 in total

Review 1.  Cytokine signaling modulates blood-brain barrier function.

Authors:  Weihong Pan; Kirsten P Stone; Hung Hsuchou; Vamshi K Manda; Yan Zhang; Abba J Kastin
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

Review 2.  Adipokines and the blood-brain barrier.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Peptides       Date:  2007-05-06       Impact factor: 3.750

3.  Seizures in Women with Preeclampsia: Mechanisms and Management.

Authors:  Marilyn J Cipolla; Richard P Kraig
Journal:  Fetal Matern Med Rev       Date:  2011-05

4.  A sublethal dose of TNFalpha potentiates kainate-induced excitotoxicity in optic nerve oligodendrocytes.

Authors:  Brandon A Miller; Fang Sun; Randolph N Christensen; Adam R Ferguson; Jacqueline C Bresnahan; Michael S Beattie
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

Review 5.  Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury.

Authors:  Hemant Kumar; Alexander E Ropper; Soo-Hong Lee; Inbo Han
Journal:  Mol Neurobiol       Date:  2016-05-18       Impact factor: 5.590

Review 6.  Cytokine transport across the injured blood-spinal cord barrier.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

7.  Cerebral microvascular IL15 is a novel mediator of TNF action.

Authors:  Weihong Pan; Chuanhui Yu; Hung Hsuchou; Reas S Khan; Abba J Kastin
Journal:  J Neurochem       Date:  2009-08-31       Impact factor: 5.372

8.  Neuroinflammation activates Mdr1b efflux transport through NFkappaB: promoter analysis in BBB endothelia.

Authors:  Chuanhui Yu; George Argyropoulos; Yan Zhang; Abba J Kastin; Hung Hsuchou; Weihong Pan
Journal:  Cell Physiol Biochem       Date:  2008-12-09

9.  Cessation of blood-to-brain influx of interleukin-15 during development of EAE.

Authors:  Hung Hsuchou; Weihong Pan; Xiaojun Wu; Abba J Kastin
Journal:  J Cereb Blood Flow Metab       Date:  2009-06-17       Impact factor: 6.200

Review 10.  Tumor necrosis factor and stroke: role of the blood-brain barrier.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Prog Neurobiol       Date:  2007-08-06       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.